Skip to main content Accessibility help
×
Home

Clinical utility of novel cardiac markers: Let the buyer beware

  • Grant Innes (a1)
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Clinical utility of novel cardiac markers: Let the buyer beware
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Clinical utility of novel cardiac markers: Let the buyer beware
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Clinical utility of novel cardiac markers: Let the buyer beware
      Available formats
      ×

Abstract

Copyright

Corresponding author

Department of Emergency Medicine, St. Paul’s Hospital, 1081 Burrard St., Vancouver BC V6Z 1Y6

References

Hide All
1.Lippi, G, Montagnana, M, Salvagno, GL, et al. Potential value for new diagnostic markers in the early recognition of acute coronary syndromes. Can J Emerg Med 2006;8(1):27––31.
2.Panju, AA, Hemmelgarn, BR, Guyatt, GH, et al. Is this patient having a myocardial infarction? JAMA 1998;280:1256–63.
3.Christenson, J, Innes,GD ,GD, Mcknight, D, et al. A clinical prediction rule for early discharge of patients with chest pain. Ann Emerg Med 2005. In press.
4.Antman, EM, Cohen, M, Bernink, PJ, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000;284:835–42.
5.Worster, A, Abu-Laban, R, Innes, GD. Diagnostic testing in emergency medicine. Can J Emerg Med 2002;4:348–55.
6.Christenson, J, Innes, G, McKnight, D, et al. Safety and efficiency of emergency department assessment of chest discomfort. CMAJ 2004;170:18037.
7.Innes, G, Christenson, J, Weaver, WD, et al. Diagnostic parameters of CK-MB and myoglobin related to chest pain duration. Can J Emerg Med 2002;4(5):322–30.
8.Worster, A, Devereaux, PJ, Heels-Ansdell, D, et al. Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome. CMAJ 2005;172:1685–90.
9.Roy, D, Quiles, J, Aldama, G, et al. Ischemia modified albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. Int J Cardiol 2004;97:297301.
10.Anwaruddin, S, Januzzi, Jr JL, Baggish, AL, et al. Ischemia-modified albumin improves the usefulness of standard cardiac bio-markers for the diagnosis of myocardial ischemia inthe emergency department setting. Am J Clin Pathol 2005;123:140–5.
11.Sinha, MK, Roy, D, Gaze, DC, et al. Role of ischemia modified albumin, a new biochemical marker ofmyocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 2004;21:2934.
12.Bassan, R, Potsch, A, Maisel, A, et al. B-type natriuretic peptide: a novel early marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation. Europ Heart J 2005;26:234–40.
13.Mueller, C, Scholer, A, Laule-Kilian, K, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004;350:647–54.

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed